TerrAscend (TSNDF) Return on Capital Employed Growth (1y) (2023 - 2026)
TerrAscend (TSNDF) Return on Capital Employed Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 1,195.00 |
| 10 | TerrAscend | 168.49 Mn | 168.02 Mn | 34.60 Mn | 57.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.00 |
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 450.00 |
| Jun 30, 2025 | 177.00 |
| Mar 31, 2025 | 101.00 |
| Dec 31, 2024 | 56.00 |
| Sep 30, 2024 | -1,259.00 |
| Jun 30, 2024 | 14,895.00 |
| Mar 31, 2024 | 6,635.00 |
| Dec 31, 2023 | 6,438.00 |
| Sep 30, 2023 | 6,666.00 |
| Jun 30, 2023 | -14,075.00 |
| Mar 31, 2023 | -6,107.00 |